Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4α.
Zheng BN, Ding CH, Chen SJ, Zhu K, Shao J, Feng J, Xu WP, Cai LY, Zhu CP, Duan W, Ding J, Zhang X, Luo C, Xie WF.
Zheng BN, et al. Among authors: duan w.
Theranostics. 2019 Apr 13;9(9):2606-2617. doi: 10.7150/thno.32344. eCollection 2019.
Theranostics. 2019.
PMID: 31131056
Free PMC article.